Fasting Glucose Variation Predicts Microvascular Risk in ACCORD and VADT is a research paper published in The Journal of Clinical Endocrinology & Metabolism (2020). On theSindex it has a DataRank of 1.1. It has been cited 24 times, with 18 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.483
From this paper's citation signal
Citation Network Contribution
0.598
From 12 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 18 citers.
National Institutes of Health
Grant: R01-067690
National Institutes of Health
Grant: 5R01-094775
National Institutes of Health
Grant: K01DK106116
National Institutes of Health
Grant: R21HL150374
National Institutes of Health
Grant: R01HG006139
National Institutes of Health
Grant: 5K01DK106116-03
Develop T2D Patient-Centered Treatment Suggestion Rule using EMR data
National Institutes of Health
Grant: 1R21HL150374-01A1
A Role for Glycemic Variation in Optimizing Management of Diabetes and Vascular Complications
National Institutes of Health
Grant: 5R01HG006139-06
Genomics, GPUs, and Next Generation Computational Statistics
NIEHS NIH HHS
Grant: P30 ES006694
FWCI
1.96
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Heterogeneous treatment effects of intensive glycemic control on major adverse cardiovascular events in the ACCORD and VADT trials: a machine-learning analysis
Additional file 1 of Heterogeneous treatment effects of intensive glycemic control on major adverse cardiovascular events in the ACCORD and VADT trials: a machine-learning analysis